CYP71B16 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to CYP71B16 Antibody

An antibody, also known as an immunoglobulin (Ig), is a protein produced by B cells that recognizes a specific antigen, triggering an adaptive immune response to eliminate it from the body . Antibodies have a Y shape and consist of four polypeptide chains: two identical heavy chains and two identical light chains . The variable domain on the antibody recognizes the antigen, while the constant domain forms the base . The portion of the antigen recognized by the antibody is called the epitope .

Generation of CYP71B16 Monoclonal Antibodies

Monoclonal antibodies against CYP11B1 and CYP11B2 (enzymes involved in aldosterone and cortisol biosynthesis) were generated by immunizing mice and rats with multiple peptides conjugated to immunogenic proteins . Effective antibodies were generated using amino acids 41-52 for CYP11B2 and amino acids 80-90 for CYP11B1 .

Specificity and Applications

The mouse monoclonal antibody CYP11B2-41 specifically stained the zona glomerulosa of adrenal glands and was effective in western blots . The rat monoclonal antibody CYP11B1-80 detected a single band in western blots and specifically stained the zona fasciculata . Immunofluorescence showed that CYP11B1 and CYP11B2 did not co-localize but CYP11B1 did co-localize with 17α-hydroxylase .

Antibody Function in Immune Response

Antibodies perform various functions during an immune response . They block antigens, preventing them from interacting with body cells, and opsonize pathogens, marking them for phagocytes . Antibodies can also bind to body cells, causing NK cells to selectively kill infected cells, and activate the immune and complement systems .

Antibody-Dependent Cell-Mediated Viral Inhibition (ADCVI)

ADCVI is an attractive target for vaccination, utilizing both adaptive and innate immune responses . ADCVI can inhibit viral replication and emerges shortly after infection, preceding neutralizing antibody responses . Viral envelopes resistant to neutralization may still be susceptible to ADCVI .

Antibodies and Viral Mutations

The Omicron variant demonstrates significant antibody evasion due to mutations in its spike protein . Key mutations like S371L confer resistance to multiple classes of antibodies . The Omicron variant is highly resistant to neutralization by available antibodies .

IgG Antibodies

IgG antibodies are the most abundant antibody class in the immune system . They target a multitude of antigens and neutralize pathogens to initiate the immune response . IgG antibodies are used in serological blood tests to assess a patient's immune status .

Rapid Antibody Discovery

A method for rapid antibody discovery uses the Illumina HiSeq platform to screen antibodies within three days .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
CYP71B16 antibody; At3g26150 antibody; MTC11.5 antibody; Cytochrome P450 71B16 antibody; EC 1.14.-.- antibody
Target Names
CYP71B16
Uniprot No.

Target Background

Database Links

KEGG: ath:AT3G26150

STRING: 3702.AT3G26150.1

UniGene: At.53501

Protein Families
Cytochrome P450 family
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is CYP71B16 and why is it important in plant research?

CYP71B16 (cytochrome P450, family 71, subfamily B, polypeptide 16) is a member of the cytochrome P450 superfamily found in Arabidopsis thaliana. It belongs to a large family of monooxygenases that catalyze many reactions involved in plant metabolism .

The enzyme is particularly significant in plant research because:

  • It is involved in the phenylpropanoid pathway, which is crucial for plant defense mechanisms and development

  • It represents one of the numerous P450 enzymes in plants that participate in specialized metabolite biosynthesis

  • Understanding its function contributes to our knowledge of plant secondary metabolism and biochemical diversity

Research methodologies targeting CYP71B16 typically include gene expression analysis, protein localization studies, and functional characterization through knockout/overexpression approaches. When designing experiments, consider that cytochrome P450 enzymes often have overlapping functions, which may require multiple gene analyses to fully understand their biological roles.

What are the standard applications for CYP71B16 antibodies in plant research?

CYP71B16 antibodies can be utilized in several experimental applications:

  • Western Blotting: For detection and quantification of CYP71B16 protein expression levels. Typical dilutions range from 1:500-1:1000 for most monoclonal antibodies against cytochrome P450 enzymes .

  • Immunohistochemistry (IHC): For localizing CYP71B16 within plant tissues to understand its spatial expression patterns.

  • Immunoprecipitation: For isolating CYP71B16 protein complexes to identify interaction partners.

  • ELISA: For quantitative measurement of CYP71B16 protein levels in plant extracts.

When designing application-specific protocols, researchers should note that membrane-bound proteins like cytochrome P450s often require optimization of extraction and sample preparation methods to maintain protein integrity and antibody recognition .

How should CYP71B16 antibodies be stored and handled for optimal performance?

Proper storage and handling are critical for maintaining antibody functionality:

  • Storage Temperature: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing cycles that can damage antibody structure .

  • Buffer Conditions: Most commercial CYP71B16 antibodies are supplied in phosphate-buffered saline (pH 7.2) with protective agents like glycerol (often at 50%) and preservatives such as ProClin 300.

  • Handling Protocol:

    • Thaw aliquots at room temperature

    • Keep on ice when working

    • Avoid vortexing (gentle mixing only)

    • Return to storage promptly after use

    • Monitor freeze-thaw cycles (document on tube)

  • Shipping Considerations: When receiving antibodies, verify cold chain maintenance and inspect for any signs of compromise before storage .

Implementing a validation protocol upon receipt of new antibody lots can help ensure consistent performance across experiments.

How can researchers validate the specificity of CYP71B16 antibodies?

Validating antibody specificity is crucial, especially given the high sequence similarity among plant cytochrome P450 family members:

  • Positive and Negative Controls:

    • Positive: Arabidopsis thaliana tissues known to express CYP71B16

    • Negative: Tissues from cyp71b16 knockout mutants or tissues where expression is absent

  • Cross-Reactivity Testing: Test against recombinant proteins of closely related CYP family members, particularly other members of the CYP71B subfamily .

  • Peptide Competition Assay: Pre-incubate the antibody with excess synthetic peptide corresponding to the immunogen. If the antibody is specific, this should eliminate signal in subsequent applications .

  • Multiple Antibody Approach: When possible, use antibodies raised against different epitopes of CYP71B16 and compare results.

  • Molecular Weight Verification: The calculated molecular weight of CYP71B16 should be verified on Western blots (similar to other CYP proteins that typically range from 50-60 kDa) .

The approach of targeting antibodies toward the C-terminus of P450 proteins has been particularly successful in producing specifically binding antibodies that distinguish between highly related P450 proteins .

What controls should be included when working with CYP71B16 antibodies?

Robust experimental design requires appropriate controls:

  • Positive Controls:

    • Recombinant CYP71B16 protein or GST-tagged partial recombinant protein

    • Plant tissue samples with confirmed high expression of CYP71B16

    • Transfected cell lines overexpressing CYP71B16

  • Negative Controls:

    • Secondary antibody-only controls to detect non-specific binding

    • Pre-immune serum controls (when available)

    • Samples from cyp71b16 knockout or knockdown plants

    • Tissues known not to express CYP71B16

  • Internal Controls:

    • Housekeeping proteins for loading control in Western blots

    • Reference genes for qRT-PCR when correlating protein with mRNA levels

    • Non-target cytochrome P450s to demonstrate specificity

  • Technical Controls:

    • Isotype controls for monoclonal antibodies

    • Blocking peptide competition assays

Document all control results thoroughly for publication and troubleshooting purposes.

How do expression patterns of CYP71B16 vary across plant tissues and developmental stages?

Understanding the spatiotemporal expression of CYP71B16 requires comprehensive analysis:

  • Tissue-Specific Expression:
    Studies of other CYP family members have shown varied expression patterns. For example, CYP78A9 expression in Arabidopsis shows specific localization in developing reproductive organs with critical functions in fruit development .

  • Developmental Regulation:
    Expression analysis should consider:

    • Vegetative growth stages

    • Flowering transition

    • Reproductive development

    • Stress responses

  • Methodological Approaches:

    • Immunohistochemistry with CYP71B16 antibodies for protein localization

    • Reporter gene fusions (promoter:GUS/GFP) for transcriptional analysis

    • qRT-PCR for quantitative expression measurements across tissues

    • In situ hybridization for high-resolution spatial expression

  • Considerations When Interpreting Results:

    • Expression may change in response to environmental stimuli

    • Post-transcriptional regulation may result in discrepancies between mRNA and protein levels

    • Closely related family members may show complementary or overlapping expression patterns

When designing experiments to map expression patterns, include tissues from multiple developmental stages and growth conditions to capture the full range of expression dynamics.

What strategies can improve the specificity of antibodies against plant cytochrome P450s like CYP71B16?

Developing highly specific antibodies against plant cytochrome P450s presents significant challenges due to sequence similarity among family members:

  • Strategic Epitope Selection:

    • Target the C-terminal region, which has been shown to be particularly successful for producing specific antibodies against P450 proteins

    • Analyze sequence alignments to identify unique regions that differ from closely related family members

    • Avoid conserved functional domains shared across the P450 superfamily

  • Antibody Production Approaches:

    • Monoclonal antibodies often provide higher specificity than polyclonal antibodies

    • Consider using recombinant antibody technologies like phage display that allow for affinity maturation and specificity enhancement

    • Employ negative selection strategies against closely related P450 proteins during antibody screening

  • Validation Using Multiple Methods:

    • Apply rigorous cross-reactivity testing against related CYP proteins

    • Use genetic knockouts as negative controls

    • Implement peptide competition assays to confirm epitope specificity

  • Advanced Purification Techniques:

    • Affinity purification against the specific immunogen

    • Cross-adsorption against related P450 proteins to remove cross-reactive antibodies

The approach of targeting the C-terminus has been demonstrated to be "both rapid and efficient at producing specifically binding antibodies" for P450 proteins, which may be applicable to CYP71B16 .

How can researchers distinguish between closely related cytochrome P450 enzymes in experimental systems?

Discriminating between structurally similar P450 enzymes requires strategic experimental design:

  • Antibody-Based Discrimination:

    • Develop highly specific antibodies targeting unique regions

    • Use epitope-specific monoclonal antibodies rather than polyclonals when possible

    • Implement double-labeling immunofluorescence to compare localization patterns

  • Activity-Based Profiling:

    • Develop substrate-specific activity assays

    • Use recombinant systems to characterize enzyme kinetics with various substrates

    • Apply chemical inhibitors with differential specificity

  • Genetic Approaches:

    • Generate and characterize single and multiple mutants

    • Create complementation lines with defined mutations

    • Employ CRISPR/Cas9 for precise gene editing

  • Mass Spectrometry Techniques:

    • Targeted proteomics approaches with unique peptide signatures

    • Analyze post-translational modifications that may differ between family members

    • Activity-based protein profiling using clickable substrate analogs

  • Expression Pattern Analysis:

    • Determine tissue-specific and developmental expression profiles

    • Study regulation under different stress conditions

    • Analyze promoter elements that drive differential expression

When designing experiments, consider that multiple P450 enzymes may have redundant functions, requiring comprehensive approaches that combine protein and genetic analyses .

What are common challenges when working with plant cytochrome P450 antibodies and how can they be overcome?

Plant cytochrome P450 antibodies present several technical challenges:

  • High Background in Plant Tissues:

    • Solution: Optimize blocking conditions (try different blockers like BSA, milk, or commercial blockers)

    • Solution: Increase washing steps and duration

    • Solution: Pre-adsorb antibodies with plant extract from knockout lines

  • Poor Signal-to-Noise Ratio:

    • Solution: Optimize protein extraction methods for membrane proteins

    • Solution: Use detergents suitable for membrane protein solubilization

    • Solution: Consider antigen retrieval methods for fixed tissues

  • Cross-Reactivity with Related P450s:

    • Solution: Use antibodies targeted to unique regions like the C-terminus

    • Solution: Validate with knockout lines or RNA interference

    • Solution: Perform Western blots with recombinant proteins of related family members

  • Inconsistent Results Between Experiments:

    • Solution: Standardize tissue collection, processing, and storage

    • Solution: Create standard operating procedures for each application

    • Solution: Use the same antibody lot when possible or validate new lots against old ones

  • Extraction Difficulties:

    • Solution: Use specialized extraction buffers for membrane proteins

    • Solution: Optimize detergent concentration and type

    • Solution: Consider using microsomal preparations rather than total protein extracts

The targeted antibody approach has been particularly effective for distinguishing between highly related P450 proteins and may help address specificity issues .

How can CYP71B16 antibodies be effectively used in plant subcellular localization studies?

Understanding the subcellular localization of CYP71B16 requires specialized approaches:

  • Immunofluorescence Microscopy Protocol:

    • Fixation: Use 4% paraformaldehyde with gentle permeabilization

    • Antigen Retrieval: May be necessary for some tissues

    • Blocking: Extended blocking (2+ hours) with BSA/normal serum

    • Primary Antibody: Incubate at 4°C overnight at optimized dilution

    • Secondary Antibody: Fluorophore-conjugated with minimal cross-reactivity

    • Counterstaining: DAPI for nuclei, ER-Tracker for endoplasmic reticulum

    • Mounting: Anti-fade mounting medium to prevent photobleaching

  • Confocal Microscopy Considerations:

    • Use appropriate laser settings to minimize autofluorescence

    • Employ spectral unmixing for plant tissues with high autofluorescence

    • Include single-label controls for each fluorophore

  • Subcellular Fractionation Approach:

    • Prepare microsomal, cytosolic, and other subcellular fractions

    • Analyze each fraction by Western blotting with CYP71B16 antibody

    • Include markers for each subcellular compartment (e.g., BiP for ER)

  • Co-localization Studies:

    • Use well-established markers for plant organelles

    • Calculate co-localization coefficients (Pearson's, Manders')

    • Perform line scan analysis across subcellular structures

  • Validation Approaches:

    • Compare localization of fluorescent protein fusions

    • Confirm with electron microscopy immunogold labeling

    • Verify with subcellular fractionation biochemical analysis

Most plant cytochrome P450 enzymes are expected to localize to the endoplasmic reticulum, but exceptions exist. The related CYP4Z1 in human cells has been shown to localize to the plasma membrane, demonstrating that cytochrome P450 localization can vary .

How are new antibody technologies being applied to improve cytochrome P450 research?

Recent technological advances offer new opportunities for cytochrome P450 research:

  • Antibody Engineering Approaches:

    • Recombinant antibody fragments (Fab, scFv) for improved tissue penetration

    • Bispecific antibodies capable of recognizing multiple epitopes simultaneously

    • Nanobodies (VHH) derived from camelid antibodies for enhanced stability and penetration

  • Generative Adversarial Networks (GANs) for Antibody Design:

    • Machine learning approaches to design antibodies with improved specificity

    • The Antibody-GAN can generate synthetic antibodies with desired properties

    • Transfer learning to bias antibody properties toward improved stability and reduced immunogenicity

  • High-Throughput Screening Technologies:

    • Functional screening methods compatible with next-generation sequencing

    • New genotype-phenotype linked antibody screening platforms

    • Phage display technology for rapid identification of high-affinity binders

  • Antibody Glycoengineering:

    • Controlling Fc glycosylation patterns to enhance antibody properties

    • Afucosylation strategies to modify antibody effector functions

    • Site-specific conjugation technologies for improved homogeneity

These technologies could significantly improve the specificity and utility of antibodies targeting plant cytochrome P450s like CYP71B16, enabling more precise functional studies.

What future research directions are being pursued in plant cytochrome P450 antibody development?

Future research in plant cytochrome P450 antibody development is focusing on several promising directions:

  • Multi-Epitope Targeting Strategies:

    • Development of antibody cocktails targeting different regions of CYP proteins

    • Bispecific antibodies that recognize two distinct epitopes for improved specificity

    • Domain-specific antibodies for functional analysis

  • Systems Biology Approaches:

    • Comprehensive antibody panels for all members of plant CYP subfamilies

    • Integrated proteomics and metabolomics to connect CYP protein levels with metabolite profiles

    • Network analysis of CYP enzyme interactions and regulatory pathways

  • Advanced Imaging Applications:

    • Super-resolution microscopy for precise subcellular localization

    • Live-cell imaging using cell-permeable antibody fragments

    • Multiplexed imaging of multiple CYP enzymes simultaneously

  • Therapeutic Applications in Agricultural Biotechnology:

    • Antibodies as tools for modulating plant metabolism

    • Engineering plants to express antibodies that modify CYP function

    • Targeting key CYP enzymes to enhance plant resistance

  • Functional Genomics Applications:

    • Extending targeted antibody approaches used for P450 proteins to the wider field of functional genomics

    • Development of antibody-based protein knock-down strategies

    • Using antibodies to track protein dynamics during plant development

These advances will enable more comprehensive understanding of plant cytochrome P450 functions and potentially lead to novel applications in agriculture and biotechnology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.